Work

Prolonged Post-Transplant Ruxolitinib Therapy is Associated with Protection from Severe Gvhd after Allogeneic HCT

Year: 2022

Type: article

Source: Transplantation and Cellular Therapy

DOI: 10.1016/s2666-6367(22)00553-x

Authors: Zachariah DeFilipp, Haesook T. Kim, Laura Knight, Devon Kelley, Michael T. Byrne, Mark A. Schroeder, Roni Tamari, Sarah A. Wall, Sumithira Vasu, Sameem Abedin, Areej R. El-Jawahri, Steven L. McAfee, Yi-Bin Chen, Gabriela Hobbs

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650

OpenAlex ID: W4220655714

FWCI: 0.911

Cites:

Cited by: 6

Related to: 10